Hints and tips:
...Last week, Revance announced it was teaming up with Mylan , the world’s largest generic drugmaker by market value, to develop the biosimilar product, prompting a sell-off in Allergan’s shares....
...But buying Ratiopharm would catapult it into the generic big leagues, on a par with companies such as Mylan and Watson that each control about 6 per cent of global sales, according to BCC....
...Permira has linked with Hank Klakurka, the former chief executive of Merck Generics, which he quit after it was sold to Mylan Laboratories for €4.9bn in 2007....
...Israeli generic group Teva, French drugmaker Sanofi-Aventis, US company Mylan and a series of financial investors are believed to be among the possible suitors....
...A number of the largest potential acquirers have already sealed deals: Sandoz, part of Novartis of Switzerland, bought Hexall of Germany; and Mylan of the US acquired Merck of Germany’s generic arm....
...The generic drugs sector has consolidated, with companies such as Teva, Actavis and Mylan primarily focused on producing generics....
International Edition